Dyclonine
NERVOUS SYSTEM
Also known as: dyclocaine, dyclonin, dyclonine HCl, dyclonine hydrochloride
Data last refreshed: (DrugCentral release 2024-11-01)
Key facts
Dyclonine is an ofp drug catalogued in DrugCentral. DrugCentral lists 2 molecular targets, including ACHE and SCN10A. Recorded indications include Itching of skin, Local anesthesia, Minor Skin Wound Pain and Mouth Irritation.
- Approval status: ofp.
- Molecular targets: ACHE and SCN10A (2 listed in DrugCentral).
- Indications: Itching of skin, Local anesthesia, Minor Skin Wound Pain, Mouth Irritation and Prevent Minor Bacterial Skin Infection and others.
- ATC code: N01BX02 (Other local anesthetics).
- Molecular formula: C18H27NO2; molecular weight 289.42 g/mol.
Indications & contraindications
Drug–disease relationships curated by DrugCentral (OMOP / SNOMED concepts).
Indications (7)
- Itching of skin
- Local anesthesia
- Minor Skin Wound Pain
- Mouth Irritation
- Prevent Minor Bacterial Skin Infection
- Skin irritation
- Suppression of the Gag Reflex
Contraindications (7)
- Bleeding hemorrhoids
- Conduction disorder of the heart
- Decreased respiratory function
- Denuded skin
- Disorder of mucous membrane
- Open wound
- Seizure disorder
Mechanism & targets
Molecular targets (2)
| Target | Gene | Action | Activity |
|---|---|---|---|
| Acetylcholinesterase | ACHE | unknown | IC50 6.74 |
| Sodium channel protein type 10 subunit alpha | SCN10A | blocker | — |
Regulatory approvals (1)
| Date | Agency | Marketed as | Applicant | Orphan |
|---|---|---|---|---|
| — | FDA | — | — |
ATC classification
| ATC code | Therapeutic hierarchy |
|---|---|
N01BX02 | NERVOUS SYSTEM › ANESTHETICS › ANESTHETICS, LOCAL › Other local anesthetics |
R02AD04 | RESPIRATORY SYSTEM › THROAT PREPARATIONS › THROAT PREPARATIONS › Anesthetics, local |
Reported adverse-event signals
Strongest FDA FAERS disproportionality signals (log-likelihood ratio). A signal is a statistical association in spontaneous reports, not proof that the drug causes the event.
| MedDRA term | LLR |
|---|---|
| Heart rate abnormal | 193.0 |
| Blood magnesium decreased | 152.9 |
| Lymphadenitis | 136.6 |
| Muscle twitching | 136.0 |
| Soft tissue disorder | 127.3 |
| Infection | 117.7 |
| Clostridium difficile infection | 115.9 |
| Productive cough | 105.4 |
| Pneumonia viral | 102.7 |
| Thrombosis | 83.1 |
| Liver function test abnormal | 79.3 |
| White blood cell count decreased | 76.8 |
Chemical structure
Full physicochemical, ADMET and 3D-structure analysis of Dyclonine is on its molecule page.
| Molecular formula | C18H27NO2 |
|---|---|
| Molecular weight | 289.42 g/mol |
| CAS number | 586-60-7 |
| InChIKey | BZEWSEKUUPWQDQ-UHFFFAOYSA-N |
| PubChem CID | 3180 |
Frequently asked questions
Answers are generated from the structured data on this page, not written by hand.
What is Dyclonine used for?
DrugCentral lists the following indications for Dyclonine: Itching of skin, Local anesthesia, Minor Skin Wound Pain, Mouth Irritation, Prevent Minor Bacterial Skin Infection, Skin irritation and Suppression of the Gag Reflex.
How does Dyclonine work?
Its molecular targets in DrugCentral include ACHE and SCN10A (blocker).
What is the chemical formula of Dyclonine?
Dyclonine has the molecular formula C18H27NO2 and a molecular weight of 289.42 g/mol.
Browse: all drugs starting with D · drug guides by category · protein targets A–Z.
Sources
- DrugCentral drug card 974 — structure, indications, targets, approvals, pharmacologic classes (CC BY-SA 4.0)
- ChEMBL CHEMBL1200478 — compound record and bioactivity
- PubChem CID 3180 — chemical identifiers
- DrugBank DB00645 — drug record
- FDA UNII 078A24Q30O — substance identity
- DailyMed: FDA labels for Dyclonine — current prescribing information (label search)
- UniProt P22303 (ACHE) — target protein
- UniProt Q9Y5Y9 (SCN10A) — target protein
- FDA Adverse Event Reporting System (openFDA FAERS) — adverse-event signals, as aggregated by DrugCentral
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.